IN THE HEART, ␤ 1 -adrenergic signaling plays a key role in regulating physiological responses including action potential generation, cytosolic Ca 2ϩ transients, and contraction. Catecholamines (e.g., noradrenaline and adrenaline) stimulate ␤ 1 -adrenergic receptors (␤ 1 -ARs) coupled to stimulatory G (G s ) proteins, and thus activate adenylyl cyclase, which produces cyclic AMP (cAMP). Increased levels of cAMP enhance the activity of cAMP-dependent protein kinase A (PKA). PKA promotes phosphorylation of target proteins, such as ion channels, transporters, and exchangers, in plasma and organelle membranes. Consequently, ␤ 1 -AR stimulation induces positive inotropic (enhanced cardiac contractility) and chronotropic (increased heart rate) responses. Synthesized cAMP is degraded by phosphodiesterase (PDE), and phosphorylated proteins are dephosphorylated by protein phosphatase. Although the ␤ 1 -adrenergic signaling system has been studied extensively, most experimental approaches have focused on specific targets without considering their interactions with other proteins. Therefore, a comprehensive mathematical cardiac model that incorporates the activity of membrane proteins and their downstream signals is necessary for in-depth understanding of cardiac function.
Mathematical model analyses based on experimental data were started in the 1950s. The first milestone was the quantitative analysis of the initiation and propagation of action potentials in nerve axons, the Hodgkin-Huxley model (1952) (Fig. 1A) (4) , an achievement for which they received the Nobel Prize in Physiology or Medicine (1963) . The modification of the Hodgkin-Huxley equations to account for additional ion channels led to the development of a simulation model of action and pacemaker potentials in cardiac myocytes (1962) (9) . Later, mathematical cardiac models were extended by incorporating new electrophysiological kinetics: e.g., the DiFrancesco-Noble model (1985), the Luo-Rudy model (1994) , and the Kyoto model (2003) . Furthermore, computational models of the ␤ 1 -adrenergic signaling system in cardiac myocytes have been constructed by including biochemical parameters associated with the ␤ 1 -adrenergic pathway.
In this issue of American Journal of Physiology-Cell Physiology, Grinshpon and Bondarenko (3) simulate physiological responses (action potentials, cytosolic Ca 2ϩ mobilization, and Na ϩ influx) to relatively moderate stimulation of ␤ 1 -ARs using a compartmentalized mathematical model of the ␤ 1 -adrenergic signaling system in mouse ventricular myocytes. This "Bondarenko" model includes a description of biochemical parameters involved in the ␤ 1 -adrenergic signaling that modulates ionic homeostasis and electrical activity in ventricular myocytes (2) . In addition, the Bondarenko model is characterized by the assumption that the target proteins of PKA phosphorylation following ␤ 1 -AR stimulation are localized in three subcellular compartments: caveola, extracaveola, and cytosol (Fig.  1B) .
Similar simulation studies of cardiac myocytes incorporated parameters obtained using high concentrations of isoproterenol (1-10 M), a ␤ 1 -AR agonist. However, more physiological simulations using low isoproterenol concentrations (0.01-1 M) are required to reproduce cardiac function. Experimental data indicate that low concentrations of isoproterenol do not affect electrocardiogram (ECG) parameters and mortality (6), but elicit an increased heart rate (5) in mice. The Bondarenko simulation demonstrates that the action potential prolongation after ␤ 1 -AR stimulation peaks at a low isoproterenol concentration (0.01 M), while the cytosolic Ca 2ϩ transients saturate at higher concentrations (0.1-1 M). This model clarifies that this distinct behavior is produced by the differential responsiveness of three channel currents [L-type Ca 2ϩ current (I CaL ), ultrarapidly activating delayed rectifier K ϩ current (I Kur ), and rapidly inactivating transient outward K ϩ current (I Kto,f )] to the isoproterenol concentration. In addition, moderate stimulation with 0.01 M isoproterenol promotes Ca 2ϩ influx but has only a slight effect on Na ϩ influx. On the other hand, strong stimulation with 1 M isoproterenol causes larger changes in cytosolic Ca 2ϩ and Na ϩ concentration. The simulated data of moderate ␤ 1 -AR stimulation using the Bondarenko model are generally consistent with the corresponding experimental data for cardiac myocytes.
The Bondarenko model includes biochemical parameters associated with PKA and PDE in addition to the electrophysiological kinetics of mouse ventricular myocytes. Recently, PKA inhibitors have been considered to be a potential candidate of cardioprotective drugs for patients with cardiac infarction and heart failure (7). In addition, specific PDE4 inhibitors are employed for the treatment of asthma and chronic obstructive pulmonary disease (COPD) (1). Thus, simulating the effects of these inhibitors on electrical activity and cytosolic Ca 2ϩ dynamics is important for evaluating their cardiac effects and predicting the adverse effects on the heart. The present cardiac simulation shows that H-89, a PKA inhibitor, causes shortening of action potential duration due to increased I Kto,f and reduced I CaL , and a smaller Currently, computational simulations of cardiac electrophysiology, which have been extensively verified by experimental data, are widely used as powerful tools for drug discovery, design, and safety assessment (8) . The approach has proved to be particularly useful for prediction of druginduced proarrhythmic potentials, as well as for elucidating the mechanisms of action of cardiovascular drugs. The prolongation of QT interval on ECG, which is caused by blockade of the rapidly activating delayed rectifier K ϩ current (I Kr ), attributable to hERG (human ether-a-go-gorelated gene, K v 11.1) channel activity, requires particular attention during drug screening. Drug-induced QT prolongation can trigger serious side effects such as torsade de pointes (ventricular tachycardia) and sudden cardiac death. Such drugs should be withdrawn as soon as possible from the candidate list. More recently, a mathematical model of ventricular myocytes was used for the in silico prediction of drug therapy for catecholaminergic polymorphic ventricular tachycardia (CPVT) (10) .
In conclusion, mathematical cardiac models can reconstruct cardiac function in health and disease and contribute to further understanding of physiological functions of the heart, the elucidation of pathological mechanisms responsible for cardiac disease, and the development of drugs for both cardiovascular and noncardiovascular diseases.
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